Recurrent Melanoma: Clinical Trials

7 trials for Recurrent Melanoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Terminated 7
Phase 23Terminated 3

Follow Recurrent Melanoma: new trials by email Literature Review of Recurrent Melanoma trials Research Report on Recurrent Melanoma

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery
cabozantinib-s-malate, vemurafenib, laboratory biomarker analysis - Recurrent Melanoma, Stage IIIA Melanoma
Phase 1TerminatedNational Cancer Institute (NCI)52013-05-012014-09-25
Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma
Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine, Laboratory Biomarker Analysis - Recurrent Melanoma, Stage IIIB Skin Melanoma
Phase 1TerminatedRoswell Park Cancer Institute102013-03-262022-07-22
Ipilimumab and Local Radiation for Selected Solid Tumors
Ipilimumab, Radiation therapy - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Phase 1TerminatedStanford University32013-02-012024-01-24
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer
Cognitive Assessment, Gamma-Secretase Inhibitor RO4929097, Laboratory Biomarker Analysis - Adult Solid Neoplasm, Extensive Stage Lung Small Cell Carcinoma
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)52010-10-012024-11-19
Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma
therapeutic autologous lymphocytes, aldesleukin, denileukin diftitox - Recurrent Melanoma, Stage III Melanoma
Phase 1 / Phase 2TerminatedFred Hutchinson Cancer Center32009-07-012022-11-15
Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
ipilimumab - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Phase 1TerminatedNational Cancer Institute (NCI)262002-03-012018-09-05
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma
allogeneic lymphocytes, anti-thymocyte globulin, cyclophosphamide - Stage IV Melanoma, Recurrent Melanoma
Phase 1 / Phase 2TerminatedNational Heart, Lung, and Blood Institute (NHLBI)1999-01-012024-03-04

Narrower conditions

Melanoma (7)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Colonic Neoplasms (1)  ·  Congenital Abnormalities (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Intraocular Lymphoma (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myeloid, Acute (1)

Broader conditions

Neoplasms by Histologic Type (7)  ·  Neoplasms by Site (7)  ·  Neoplasms, Germ Cell and Embryonal (7)  ·  Neoplasms, Nerve Tissue (7)  ·  Neuroectodermal Tumors (7)  ·  Neuroendocrine Tumors (7)  ·  Nevi and Melanomas (7)  ·  Skin Diseases (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Neoplasms (6)  ·  Skin Neoplasms (6)  ·  Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Chronic Disease (2)  ·  Disease Attributes (2)

Interventions

CTLA-4 Antigen (2)  ·  Ipilimumab (2)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1)  ·  Antilymphocyte Serum (1)  ·  Biopsy (1)  ·  Cyclophosphamide (1)  ·  Immunohistochemistry (1)  ·  Interleukin-2 (1)  ·  Mental Status and Dementia Tests (1)  ·  Polymerase Chain Reaction (1)  ·  Radiation (1)  ·  Radiosurgery (1)  ·  Radiotherapy (1)  ·  Vemurafenib (1)  ·  aldesleukin (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Fred Hutchinson Cancer Center (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Roswell Park Cancer Institute (1)  ·  Stanford University (1)

Countries

United States (7)

Top investigators

Frank Hodi (1)  ·  George A. Fisher, MD, PhD (1)  ·  Jason Luke (1)  ·  John Kane (1)  ·  Morris D Groves (1)  ·  Richard W. Childs (1)  ·  Sylvia Lee (1)

NIH funding

K12CA076930 (1), N01CM00039 (1), P30CA006516 (1), P30CA016672 (1), R21CA105776 (1), R21CA137647 (1), U01CA062461 (1), U01CA062490 (1), U01CA069852 (1), U01CA076576 (1), UM1CA186709 (1)